LAVA Medtech Acquisition Corp. Warrants
LVACW
LVACW was delisted on the 12th of May, 2023.
13 hedge funds and large institutions have $1.54M invested in LAVA Medtech Acquisition Corp. Warrants in 2021 Q4 according to their latest regulatory filings, with 13 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$255K |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$192K |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$96.2K |
| 4 |
SCM
Saba Capital Management
New York
|
+$84.2K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$79.4K |
Top Sellers
LVACW Hedge Fund Activity: Q4 2021 in Review
13 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Warrants (LVACW) for Q4 2021, worth a combined $1.54M.
Buyers outnumbered sellers: 13 funds opened new LVACW positions and 0 closed out — a net gain of 13 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Beryl Capital Management, opening a new position worth an estimated $255K.
- 13 institutional investors held LAVA Medtech Acquisition Corp. Warrants (LVACW) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $1.54M of LAVA Medtech Acquisition Corp. Warrants stock for Q4 2021.
- 13 funds opened new LAVA Medtech Acquisition Corp. Warrants positions in Q4 2021 and 0 closed out, a net change of +13 holders.
- The largest LAVA Medtech Acquisition Corp. Warrants buyer in Q4 2021 was Beryl Capital Management, an estimated $255K added.
Based on aggregated 13F filings for Q4 2021.